stars 1 stars 2 stars 3

Trilogie was founded to solve a critical gap in ubiquitin-proteasome system (UPS) research: the paucity of high-specific-activity, biologically validated reagents and services that reflect the true complexity of UPS biology. Whether you’re mapping E3-substrate interactions, screening DUB inhibitors, or engineering protein degraders, we believe experimental outcomes depend on functional precision, starting with the reagents themselves. Our focus: Expression scouting and optimization for ligases, substrates, adaptors, and complex UPS proteins Mechanism-aligned assay development for ubiquitylation cascades and degrader mode-of-action studies Growing catalog of ready-to-use UPS tools designed to support academic and drug discovery researchers with reagents that perform reliably

Website https://trilogiebio.com/
Employees 8 (6 on RocketReach)
Founded 2024
Industry Biotechnology Research

Trilogie Bioscience Questions

Bradley Brasher is the Chief Science Officer of Trilogie Bioscience.

6 people are employed at Trilogie Bioscience.

Top Trilogie Bioscience Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users